Lisa Dannatt
Overview
Explore the profile of Lisa Dannatt including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
82
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Swartz M, Dannatt L, Lachman A
S Afr J Psychiatr
. 2024 Aug;
30:2244.
PMID: 39114753
Background: Cannabis is the most widely used substance worldwide, and its use is much higher among adolescents. However, adolescents are at higher risk of negative sequelae secondary to this use,...
2.
Shoib S, Saeed F, Philip S, Chandradasa M, Das S, de Filippis R, et al.
Ind Psychiatry J
. 2024 Jun;
33(1):30-40.
PMID: 38853796
Background: The coronavirus disease (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has detrimental effects on physical and mental health. Patients with severe mental illness are...
3.
Scheibein F, Caballeria E, Taher M, Arya S, Bancroft A, Dannatt L, et al.
JMIR Hum Factors
. 2023 Dec;
10:e46678.
PMID: 38085569
Background: Substance use trends are complex; they often rapidly evolve and necessitate an intersectional approach in research, service, and policy making. Current and emerging digital tools related to substance use...
4.
Ransing R, de la Rosa P, Pereira-Sanchez V, Handuleh J, Jerotic S, Gupta A, et al.
Trends Psychiatry Psychother
. 2021 Nov;
44(Suppl 1):e20210263.
PMID: 34735077
Introduction: Varying public views on cannabis use across countries may explain the variation in the prevalence of use, policies, and research in individual countries, and global regulation of cannabis. This...
5.
Scheibein F, Stowe M, Arya S, Morgan N, Shirasaka T, Grandinetti P, et al.
Front Psychiatry
. 2021 Apr;
12:634309.
PMID: 33796034
No abstract available.
6.
Dannatt L, Ransing R, Calvey T, Scheibein F, Saad N, Shirasaka T, et al.
Front Psychiatry
. 2021 Mar;
12:634515.
PMID: 33762979
No abstract available.
7.
Stowe M, Calvey T, Scheibein F, Arya S, Saad N, Shirasaka T, et al.
J Addict Med
. 2020 Oct;
14(6):e287-e289.
PMID: 33009167
: Globally, there are concerns about access to healthcare and harm reduction services for people who use drugs (PWUD) during the coronavirus disease 2019 (COVID-19) pandemic. Members from the Network...
8.
Calvey T, Scheibein F, Saad N, Shirasaka T, Dannatt L, Stowe M, et al.
J Addict Med
. 2020 Sep;
14(6):e284-e286.
PMID: 32909983
: Alcohol use is a major risk factor for infectious disease and reduction of harms associated with alcohol consumption are essential during times of humanitarian crises, such as the COVID-19...
9.
Okafor C, Stein D, Dannatt L, Ipser J, van Nunen L, Lake M, et al.
Drug Alcohol Rev
. 2019 Dec;
39(3):216-222.
PMID: 31863530
Introduction And Aims: As South Africa, especially the Western Cape Province, faces an epidemic of methamphetamine use disorder, therapeutic approaches suited to the South African context are needed. This secondary...
10.
Goldstone D, Bantjes J, Dannatt L
Subst Abuse Treat Prev Policy
. 2018 Dec;
13(1):47.
PMID: 30526637
Background: People with substance use disorders (PWSUDs) are a clearly delineated group at high risk for suicidal behaviour. Expert consensus is that suicide prevention strategies should be culturally sensitive and...